{"disease":{"id":"ush2a","name":"ush2a"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04820244","title":"Characterizing Rate of Progression in USHer Syndrome (CRUSH) Study","phase":"","overall_status":"UNKNOWN","enrollment_count":36,"lead_sponsor_name":"Radboud University Medical Center","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}